SIMANCAS RACINES, DANIEL ALEJANDRODANIEL ALEJANDROSIMANCAS RACINESGiuseppe AnnunziataLudovica VerdeFederica Fascì-SpurioREYTOR GONZÁLEZ, CLAUDIA MARÍACLAUDIA MARÍAREYTOR GONZÁLEZGiovanna MuscogiuriEvelyn Frias-ToralLuigi Barrea2025-03-122025-03-122025-01-1110.1007/s13679-024-00597-6https://cris.ute.edu.ec/handle/123456789/1209Purpose of Review: This narrative review explores the role of Medical Nutritional Therapy (MNT) in managing Metabolic-Associated Steatotic Liver Disease (MASLD), previously known as nonalcoholic fatty liver disease. It aims to examine the effectiveness of specific nutritional strategies in preventing and treating this obesity-linked liver disease. Recent Findings: Emerging evidence underscores the benefits of the Mediterranean diet, low-carbohydrate diets, and intermittent fasting in reducing liver fat, improving insulin sensitivity, and mitigating inflammation. Supplementing with vitamin E, omega-3 fatty acids, and silymarin can potentially reduce liver fibrosis and promote liver health. Summary: MNT is a key intervention for MASLD management, emphasizing dietary patterns, caloric restriction, and nutraceutical supplementation. Integrating these strategies with lifestyle modifications, including regular physical activity, offers a comprehensive approach to improving metabolic and liver outcomes in patients with MASLD. Further research is needed to refine and personalize these therapeutic interventions.Liver fibrosisMedical Nutritional Therapy (MNT)Mediterranean dietMetabolic-Associated Steatotic Liver Disease (MASLD)Nutraceutical supplementationObesitytext::journal::journal article